According to a study conducted by scientists at Weill Cornell Medicine, the vertebral bones that make up the spine originate from a special kind of stem cell that secretes a protein that encourages tumour metastasis. The finding opens up a new area of study into spinal illnesses, sheds light
A recent study from Karolinska Institutet published in The Journal of Clinical Investigation shows that vitamin C and other antioxidants cause the growth of new blood vessels in lung cancer tumours. The discovery supports the notion that antioxidant-rich dietary supplements can hasten cancer
A study performed by UCLA Jonsson Comprehensive Cancer Centre researchers gave new light on why tumours that have spread to the brain from other parts of the body react to immunotherapy whereas glioblastoma, an aggressive brain cancer, does not.
The mineralization of the bone matrix, a fibrous mesh of organic and inorganic components that determines the distinct biochemical and biomechanical properties of our skeleton, has now been discovered by an interdisciplinary Cornell team as a new mechanism controlling tumour growth in the sk
Tumour cells are known to be fickle sleepers, typically lying dormant in distant tissues for years before reactivating and producing metastasis. Numerous elements, ranging from cells and molecules to other components in the so-called tissue microenvironment, have been researched to determine
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t
Resistance to therapy and metastasis, or the ability to expand outside the organ of origin, are key concerns in cancer because they give cancer the upper hand.
Cancer cells that begin metastasis, or the spread of the sickness from its origin, differ from cancer cells that remain in the original tumour. Differentiating metastasis-initiating cell types can assist clinicians in determining the severity of cancer and developing a therapy plan.
Cancer cells that commence metastasis, or the spread of the illness from its originating location, vary from cancer cells that remain in the original tumour. Differentiating metastasis-initiating cell types can help doctors identify the severity of malignancy and plan a treatment plan.
A team of researchers has uncovered how cancer evades the immune system and spreads throughout the body and is investigating ways to disable this potentially harmful trait.
Options for treatment are limited when cancer spreads to the brain. The majority of medications made to fight metastases either cannot penetrate the blood-brain barrier or are ineffective against brain metastases.